KYTX

MODERATE

Kyverna Therapeutics, Inc.

CIK: 0001994702

Buy (50% confidence)

Last activity: Dec 18, 2025

Financial Metrics

As of Dec 31, 2024 (10-K)

Net Income -$55.50M

Insider	Buys	Sells	Net Value	Holdings
SEIDENBERG BETH C DIRECTOR	1	0	$1000K	869,317 shares $6.52M
Westlake BioPartners Opportunity Fund I, L.P. TEN_PERCENT_OWNER	1	0	$1000K	869,317 shares $6.52M
Walker Karen Marie Chief Technology Officer	0	1	-$293K	22,636 shares $276K

BUY SEIDENBERG BETH C (DIRECTOR)

133,333 shares @ $7.50

$1000K

Dec 18, 2025

Conviction: | View SEC Filing →

BUY Westlake BioPartners Opportunity Fund I, L.P. (TEN_PERCENT_OWNER)

133,333 shares @ $7.50

$1000K

Dec 18, 2025

Conviction: | View SEC Filing →

SELL Walker Karen Marie (Chief Technology Officer)

23,998 shares @ $12.20

$293K

Dec 15, 2025

Conviction: | View SEC Filing →

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.